Influence of heparin treatment on biochemical markers of an activation of the coagulation system
- 1 May 1992
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 66 (2-3), 121-131
- https://doi.org/10.1016/0049-3848(92)90182-a
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolismThe Lancet, 1991
- Investigations of Coagulation System and Fibrinolysis in Patients with Disseminated Adenocarcinomas and Non-Hodgkin’s LymphomasOncology, 1990
- Influence of a low molecular weight heparin on the inhibition of factor Xa and thrombin in hip surgeryThrombosis Research, 1989
- Measurement of Plasma D-Dimer for Diagnosis of Deep Venous ThrombosisAmerican Journal of Clinical Pathology, 1989
- Drug prevention of venous thromboembolism in high risk postoperative patientsThrombosis Research, 1988
- The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activationBlood, 1987
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 1983
- Identification of D dimer-E complex in disseminated intravascular coagulationThrombosis Research, 1980
- Effect of anticoagulant treatment measured by fibrinopeptide a (fpA) in patients with venous thrombo-embolismThrombosis Research, 1980